Arrowhead Pharmaceuticals (HDP1.XETRA) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.93
-0.89
-0.84
-0.79

Details

Expected EPS
-0.9333291713199999
Actual EPS
-0.7929831
Surprise EPS
0.14
Surprise Percent
+15.04%

Description

Arrowhead Pharmaceuticals (HDP1.XETRA) has reported earnings of -0.7929831 per share for Q2 2026.

0 Comments

Share your thoughts